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Growing awareness of cerebellar involvement in addiction is based on the cerebellum’s
intermediary position between motor and reward, potentially acting as an interface
between motivational and cognitive functions. Here, we examined the impact of acute
and repeated cocaine exposure on the two main signaling systems in the mouse cere-
bellum: the endocannabinoid (eCB) and glutamate systems. To this end, we investigated
whether eCB signaling-related gene and protein expression {cannabinoid receptor type 1
receptors and enzymes that produce [diacylglycerol lipase alpha/beta (DAGLα/β) and N -acyl
phosphatidylethanolamine phospholipase D (NAPE-PLD)] and degrade [monoacylglycerol
lipase (MAGL) and fatty acid amino hydrolase (FAAH)] eCB} were altered. In addition, we
analyzed the gene expression of relevant components of the glutamate signaling system
[glutamate synthesizing enzymes liver-type glutaminase isoform (LGA) and kidney-type
glutaminase isoform (KGA), metabotropic glutamatergic receptor (mGluR3/5), NMDA-
ionotropic glutamatergic receptor (NR1/2A/2B/2C) and AMPA-ionotropic receptor subunits
(GluR1/2/3/4)] and the gene expression of tyrosine hydroxylase (TH), the rate-limiting
enzyme in catecholamine biosynthesis, because noradrenergic terminals innervate the
cerebellar cortex. Results indicated that acute cocaine exposure decreased DAGLα
expression, suggesting a down-regulation of 2-arachidonylglycerol (2-AG) production, as
well as gene expression ofTH, KGA,mGluR3 and all ionotropic receptor subunits analyzed in
the cerebellum.The acquisition of conditioned locomotion and sensitization after repeated
cocaine exposure were associated with an increased NAPE-PLD/FAAH ratio, suggesting
enhanced anandamide production, and a decreased DAGLβ/MAGL ratio, suggesting
decreased 2-AG generation. Repeated cocaine also increased LGAgene expression but had
no effect on glutamate receptors.These ﬁndings indicate that acute cocaine modulates the
expression of the eCB and glutamate systems. Repeated cocaine results in normalization
of glutamate receptor expression, although sustained changes in eCB is observed. We
suggest that cocaine-induced alterations to cerebellar eCB should be considered when
analyzing the adaptations imposed by psychostimulants that lead to addiction.
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INTRODUCTION
The neurobiological mechanisms underlying the formation,
maintenance and retrieval of drug-related behaviors have
been associated with a neuroanatomical circuit to which
Abbreviations: 2-AG, 2-arachidonylglycerol; AEA, anandamide; CB1, cannabinoid
receptor type 1; CL, conditioned locomotion; CPP, conditioned place preference;
CS, cocaine sensitization; DA,dopamine; DAGLα/β, diacylglycerol lipase alpha/beta;
eCBs, endocannabinoids; FAAH, fatty acid amino hydrolase; GluR1/2/3/4,
AMPA-ionotropic glutamatergic receptor; Hc, hippocampus; KGA, kidney-type
the contribution of the cerebellum is not considered.
Reward-associated conditioned behaviors are controlled by
dopamine (DA)-glutamate interactions in regions of the
glutaminase isoform; LGA, liver-type glutaminase isoform; MAGL, monoacylglyc-
erol lipase; mGluR, metabotropic glutamatergic receptor; NAc, nucleus accumbens;
NAE, N-acylethanolamine; NAPE-PLD, N-acyl phosphatidylethanolamine phos-
pholipaseD;NR1/2A/2B/2C,NMDA-ionotropic glutamatergic receptor; PFCx, pre-
frontal cortex; RT-qPCR, reverse-transcription real-time quantitative-polymerase
chain reaction; Str, dorsal striatum.
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mesolimbic pathway, such as the ventral tegmental area (VTA),
nucleus accumbens (NAc), prefrontal cortex (PFCx), dorsal stria-
tum (Str), hippocampus (Hc) and others (Bower and Parsons,
2003). Neuromodulatory systems, such as the endocannabinoid
(eCB) signaling system, participate in the control of the DA-
glutamate interactions that sustain drug-associated conditioning.
Thus, the presence of eCB in these brain pathways has been
implicated in the neurochemical and behavioral effects of psy-
chostimulants (Gorriti et al., 1999; De Vries and Schoffelmeer,
2005; Maldonado et al., 2006). Endocannabinoid production
is triggered by the activation of DA D2 receptors (Giuffrida
et al., 1999). These endocannabinoids modulate synaptic plas-
ticity through stimulation of cannabinoid receptor type 1 (CB1)
receptors located in the PFCx glutamatergic axon terminals that
innervate the Str (Gerdeman et al., 2002; Freund et al., 2003;
Piomelli, 2003; Ronesi and Lovinger, 2005; Mathur et al., 2013).
Chronic drug abuse produces a re-organization (neuroadapta-
tion) of the prefronto-striatal-limbic network via its effect on
neurotransmitter and neuromodulator systems and their func-
tional interactions (Nestler, 2005; Noori et al., 2012). Outside
this circuit, the cerebellum has a relevant catecholaminergic
innervation that modulates glutamatergic transmission. How-
ever, there is no study addressing the interactions between
these two signaling systems in the cerebellum in the context of
addiction.
It is becoming clear that the cerebellum plays a potential inter-
mediary role betweendifferent brain areas involved indrug-related
behavior, such as the prefrontal and associative non-motor cor-
tices, the basal ganglia and the limbic system (Heath et al., 1978;
Bostan and Strick, 2010). Moreover, the medial part of the cere-
bellum has bidirectional connections with dopaminergic VTA
neurons (Schweighofer et al., 2004). All of these anatomical ﬁnd-
ings challenge the traditional view of the cerebellum and support
its involvement in functional networks affected by drug addiction
(Miquel et al., 2009).
Considering both the anatomical relationship of the cerebel-
lum with major brain pathways involved in drug addiction and the
existence of a network of noradrenergic projections to the cere-
bellar cortex on which cocaine might act, it is reasonable to think
that acute/chronic cocaine use might have an impact on the main
cerebellar transmission systems. Previous works have demon-
strated that cocaine modulates not only dopaminergic activity
but also norepinephrine- and serotonin-mediated actions in the
brain (Pitts and Marwah, 1987). Thus, the action of cocaine in
noradrenergic target circuits could also contribute to the behav-
ioral response. Elevated catecholamine transmission is a primary
mediator of cocaine addiction, and repeated exposure to cocaine
is associated with the recruitment of glutaminase expression and
glutamatergic transmission (Glowinski and Axelrod, 1965; Cor-
nish and Kalivas, 2000; Malenka and Bear, 2004; Lopez-Moreno
et al., 2008; Ruiz et al., 2010; Blanco et al., 2012). Regarding the
cerebellum, the potentiating effects of cocaine on the GABA-
mediated inhibition of Purkinje neurons were not observed after
the selective depletion of noradrenergic neurons (Waterhouse
et al., 1991). Moreover, cocaine-induced sensitization augmented
the expression of cFos, jun-B, Homer 1b/c and Homer 3a/b in
the cerebellar cortex (Couceyro et al., 1994; Jiménez-Rivera et al.,
2000; Dietrich et al., 2007). These homer isoforms could be a cru-
cial link between mGluR and IP3-dependent intracellular Ca2+
signaling, which are considered relevant steps for synaptic remod-
eling and long-term adaptive changes (Szumlinski et al., 2006).
In addition, during the withdrawal period from repeated cocaine
exposure, the levels of NR1 and NR2A-NMDA glutamate recep-
tor subunits were reduced in rat cerebellum (Yamaguchi et al.,
2002).
Classic studies (Giuffrida et al., 1999; Gorriti et al., 1999) estab-
lished that both the blockade and desensitization of CB1 receptors
facilitate psychostimulant actions. Recent studies (Mereu et al.,
2013) indicate that the eCB signaling system is recruited at ﬁrst
cocaine administration to initiate plastic changes that lead to the
onset of behavioral sensitization. These plastic changes have been
shown in the prefrontocortical projections to basal ganglia neu-
rons. However, there are no available data on the impact of cocaine
combined with the induction of sensitization on the expression
of the signaling machinery for endocannabinoids and glutamate.
Because the interaction of catecholaminergic innervation on exci-
tatory synapsis in the brain has been shown to be dependent
on endocannabinoid signaling, we decided to investigate whether
similar interactions occur in the cerebellum after repeated cocaine
exposure. To this end, we investigated whether gene and pro-
tein expression of relevant components of the eCB, glutamate
signaling system (receptors and synthesis/degradation enzymes)
or the rate-limiting enzyme in catecholamine biosynthesis (tyro-
sine hydroxylase)were altered by acute cocaine administration.We
also investigated whether these factors were altered after a cocaine




The protocols for animal care and use were approved by the Ethics
and Research Committee at the Hospital Carlos Haya and Univer-
sidad de Málaga. All experimental animal procedures were carried
out in strict accordance with the European Communities directive
86/609/ECC (24 November 1986) and Spanish legislation (BOE
252/34367-91, 2005) regulating animal research. All efforts were
made to minimize animal suffering and to reduce the number of
animals used.
ANIMALS AND HOUSING
WeusedmaleC57BL/6Jmice (25± 5 g ; Charles River Laboratories
International, Wilmington, MA, USA) for behavioral procedures
and gene and protein expression analyses. All animals were main-
tained at the vivariumof theUniversity of Malaga. All animalswere
experimentally naïve and were housed in clear plastic cages in a
temperature-controlled room (22 ± 2◦C) with a 12 h light–dark
cycle (lights on at 8:00 a.m.) with free access to Purina laboratory
feed and tap water before the initiation of the experiments.
DRUGS
Cocaine-HCl was obtained from Alkaliber S.A. (Madrid, Spain),
dissolved in sterile saline (0.9% NaCl) just before experimenta-
tion, and administered intraperitoneally at doses of 10 (acute and
priming) and 20 mg/kg (cocaine conditioning).
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APPARATUS AND GENERAL PROCEDURES
All mice were handled and habituated to the injection procedures
once per day for 5 days prior to behavioral testing to reduce the
effect of the non-speciﬁc stress of being handled on test behavior.
All experiments were carried out between 08:00 and 20:00 h. The
animals were acclimated to the experimental room for 30min each
day. Performance in the open ﬁeld was recorded by a computed-
based video tracking system (Smart v2.5®, Panlab, Barcelona,
Spain). The maximum light intensity in the center of the open
ﬁeld was 100 lux. Four open ﬁelds (50 cm × 50 cm × 50 cm, Pan-
lab) with gray backgrounds were used. The animals were placed
in the center of the arena, and their behavior was recorded for
30 min. Horizontal locomotion was measured as total distance
traveled (cm).
ACUTE/REPEATED COCAINE ADMINISTRATION, CONDITIONED
LOCOMOTION, AND COCAINE SENSITIZATION
Cocaine sensitization was conducted following a consecutive four-
phase paradigm: cocaine conditioning, drug free period (resting),
conditioned locomotion (CL) probe and CS or priming test.
Firstly, two mouse groups were injected with cocaine (20 mg/kg
body weight) or vehicle (0.9% NaCl) for ﬁve consecutive days
and exposed to the open ﬁeld (cocaine conditioning). For the
next 5 days, all animals rested without the drug. Then, we eval-
uated the locomotor activity response induced by the association
between repeated administration of cocaine and the location at
which it exerted its stimulant effect by simulated administra-
tion with vehicle (CL response). On the last day, we assessed
the presence of sensitization by lower-dose cocaine administra-
tion (priming: 10 mg/kg body weight). All animals were evaluated
in the Open Field test to measure the distance traveled (cm)
for 30 min with the video tracking system, except in the drug
free period. There were four experimental groups (n = 8): ani-
mals that were conditioned with cocaine (20 mg/kg body weight)
for 5 days (chronic pretreatment), rested for 5 days and were
administered vehicle or cocaine (10 mg/kg body weight; acute
treatment) and animals that were conditioned with vehicle for
5 days (chronic pretreatment), rested for 5 days, and then were
treated with vehicle or cocaine (10 mg/kg body weight; acute
treatment). Thus, the groups of animals were (n = 8): (1)
chronic vehicle pretreatment and acute vehicle treatment (vehicle–
vehicle group), (2) chronic vehicle pretreatment and acute cocaine
treatment (vehicle–cocaine group), (3) chronic cocaine pretreat-
ment and acute vehicle treatment (cocaine–vehicle group), and
(4) chronic cocaine pretreatment and acute cocaine treatment
(cocaine–cocaine group). Animals from these four groups were
used for the behavioral studies and the gene andprotein expression
analyses.
TISSUE COLLECTION
One hour after acute treatment with vehicle or cocaine, all animals
were sacriﬁced by decapitation, and their brains were immediately
dissected out, frozen on dry ice, and stored at −80◦C. The brains
were dissected in coronal brain slice sections (1 mm thick) on
dry ice using razor blades and a mouse brain slicer matrix (Zivic
Instruments). The cerebellar cortex was precisely removed with
ﬁne surgical instruments according to the Paxinos and Franklin
(2004). Samples were stored at −80◦C until they were used for
gene and protein analyses.
RNA ISOLATION AND QUANTITATIVE REAL-TIME PCR ANALYSIS
Real-time PCR was used to quantify the relative mRNA levels
of the catecholamine synthesizing enzyme tyrosine hydroxy-
lase (TH) and the relevant receptors and synthesis/degradation
enzymes involved in eCB signaling [CB1 receptor, N-acyl phos-
phatidylethanolamine phospholipase D (NAPE-PLD), diacyl-
glycerol lipase alpha/beta (DAGLα/β), monoacylglycerol lipase
(MAGL) and fatty acid amino hydrolase (FAAH)] and glutamate
signaling [liver-type glutaminase isoform (LGA), kidney-type
glutaminase isoform (KGA), mGluR3/5 metabotropic receptors,
and NR1/2A/2B/2C-NMDA and GluR1/2/3/4- (AMPA ionotropic
receptor subunits)] in the cerebellum. Total RNA was isolated
using theTrizol®method, according to themanufacturer’s instruc-
tion (Gibco BRL Life Technologies, Baltimore, MD, USA). The
tissue was placed into 1 ml of Trizol Reagent (Invitrogen, Carls-
bad, CA, USA) and homogenized with an IKA-Ultra-Turrax®T8
(IKA-Werke GmbH, Staufen, Germany). To ensure the purity of
the mRNA sequences and exclude molecules smaller than 200
nucleotides, RNA samples were isolated with a RNeasy Minelute
CleanupKit (Qiagen,Hilden,Germany),which included digestion
with DNase I column (RNase-free DNase Set, Qiagen), accord-
ing to the manufacturers’ instructions, and puriﬁed using RNeasy
Mini Kit (Qiagen, Hilden, Germany). The total mRNA concentra-
tions were quantiﬁed using a spectrophotometer (Nanodrop 1000
Spectrophotometer, Thermo Scientiﬁc, Rochester, NY, USA) to
ensure A260/280 ratios of 1.8–2.0.
Reverse-transcriptionwas carried outwith 2μg of mRNAusing
the Transcriptor Reverse Transcriptase kit and random hexamer
primers (Transcriptor RT, Roche Diagnostic GmbH, Manheim,
Germany). Negative controls included reverse-transcription reac-
tions that omitted reverse transcriptase. The resultant cDNAswere
used as templates for quantitative real-time PCR with an iCy-
cler system (BioRad, Hercules, CA, USA) using the Quanti-Test
SYBR Green PCR kit (Qiagen, Hilden, Germany). The primers
used are described in Table 1. Oligonucleotides were provided by
Sigma-Proligo (Proligo France SAS, Paris, France).
Quantiﬁcation was carried out according to standard curves
and was run simultaneously. The samples for each reaction were
run in duplicate. The PCR product was separated by electrophore-
sis in a 1% agarose gel to verify fragment size and the absence of
contaminating fragments, quantiﬁedbymeasuring the absorbance
at 260 nm, and serially diluted to 10−5 pg/ml. Several 10-fold
dilutions (10−1–10−5) were checked for optimal cycling on the
iClycler system, and three of them were selected for the standard
curves. Each reaction was run in duplicate and contained 2.5 μl
of cDNA template, 8 μl of Master SYBR Green, 4.86 μl of PCR
Ultra Pure Water and 0.64 μl of primers in a ﬁnal reaction vol-
ume of 15 μl. Cycling parameters were 95◦C for 15 min to activate
DNA polymerase, then 30–40 cycles at 94◦C for 15 s, temperature-
speciﬁc annealing for each primer for 30 s and a ﬁnal extension
step of 72◦C for 30 s, in which ﬂuorescence was acquired. Melting
curve analysis was performed to ensure that only a single product
was ampliﬁed. Absolute values from each sample were normalized
with regard to β-actin mRNA (constitutive gene), which was used
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Table 1 | Primers sequences used for RT-PCR1.
Gene ID GenBank accession
numbers
Forward sense primers Reverse antisense primers Product size
(bp)
Actb (β-actin) NM_007393 tacagcttcaccaccacagc aaggaaggctggaagagagc 206
TH NM_009377.1 ccaaggaaagtgtcagagttgg accctgcttgtattggaagg 150
eCB Cnr1 (CB1 receptor) NM_007726.1 gctgcaatctgtttgctcag ttgccatcttctgaggtgtg 201
Faah (FAAH) NM_010173.2 cggagagtgactgtgtggtg tcagtgcctaaacccagagg 220
Napepld (NAPE-PLD) AB_112350 gcgccaagctatcagtatcc tcagccatctgagcacattc 223
Mgll (MAGL) NM_011844.3 catggagctggggaacactg ggagatggcaccgcccatggag 240
Dagla (DAGLα) NM_198114.1 agaatgtcaccctcggaatg gcaggttgtaagtccgcaaa 153
Daglb (DAGLβ) NM_144915.2 aagcggccagatacattcac ggataagcgacacgacaaag 246
Glutamate sinthesizing Gls2 (LGA) NM_001033264 ttggaccatgcgctgcatcttg gcactcggatcatgacgcctcac 190
enzymes Gls (KGA) NM_001081081 gcgagggcaaggagatggtg ctctttcaacctgggatcagatgttc 179
Metabotropic glutamate Gmr3 (mGluR3) NM_181850.2 tgagtggtttcgtggtcttg tgcttgcagaggactgagaa 153
receptors Gmr5 (mGluR5) BC096533.1 aagaaggagaaccccaacca ttcggagactggagagtttg 179
NMDA ionotropic glutamate Grin1 (NR1) NM_008169 gtgcaagtgggcatctacaa tgggcttgacatacacgaag 157
receptor subunits Grin2a (NR2A) NM_008170 gtttgttggtgacggtgaga aagaggtgctcccagatgaa 180
Grin2b (NR2B) NM_008171 atgtggattgggaggatagg tcgggctttgaggatacttg 249
Grin2c (NR2C) NM_010350 ggaatggtatgatcggtgag ccgtgaggcacattacaaac 225
AMPA ionotropic glutamate Gria1 (GluR1) NM_008165.2 ttttctaggtgcggttgtgg cctttggagaactgggaaca 210
receptor subunits Gria2 (GluR2) NM_001039195.1 aaggaggaaagggaaacgag ccgaagtggaaaactgaacc 217
Gria3 (GluR3) NM_016886.2 caacaccaaccagaacacca atcggcatcagtgggaaa 229
Gria4 (GluR4) NM_019691.3 ttggaatgggatggtaggag taggaacaagaccacgctga 250
1Oligonucleotides were provided by Sigma-Proligo.
as a reference standard. This internal standard was chosen based
on a ﬁrst analysis of a panel of housekeeping genes that included
cyclophylin and transcription factor (speciﬁcity protein) 1.
WESTERN BLOT ANALYSIS
Western blotting was used to quantify the relative protein levels
of the eCB signaling system (CB1 receptor, NAPE-PLD,DAGLα/β,
MAGL, and FAAH) in the cerebellum. Samples were homogenized
in 50 mM Hepes buffer (pH 8) and 0.32 M sucrose buffer to obtain
membrane protein extracts. The homogenate was centrifuged at
800 g for 10 min at 4◦C, and the supernatant was centrifuged
at 40000 g for 30 min. The pellets were resuspended in 50 mM
Hepes buffer (pH 8) and pulverized using a homogenizer. Protein
concentration was measured using the Bradford protein assay.
For immunoblotting, protein samples (40 μg) were separated
on 10% (w/v) SDS-PAGE gels, transferred on to nitrocellulose
membranes (BioRad) and controlled by Ponceau Red staining.
After blocking with 5% (w/v) bovine serum albumin (BSA) in
PBST buffer (0.1% Tween 20 in PBS) at room temperature for
1 h, membranes were incubated with the primary antibodies
overnight at 4◦C, as was described previously (Suarez et al., 2008):
anti-CB1 receptor (Cayman, cat. no. 101500) diluted 1:200,
anti-DAGLα (produced in our laboratory) diluted 1:100, anti-
DAGLβ (produced in our laboratory) diluted 1:100, anti-NAPE-
PLD (produced in our laboratory) diluted 1:100, anti-FAAH
(Cayman, cat. no. 101600) diluted 1:100 and anti-MAGL
(Cayman, cat. no. 100035) diluted 1:200. After incubation with
a peroxidise-conjugated goat anti-rabbit IgG (H + L) antibody
(Promega) diluted 1:2500 for 1 h at room temperature, the mem-
branes were revealed by the Western Blotting Luminol Reagent
kit (Santa Cruz Biotechnology). Speciﬁc protein bands were
visualized and quantiﬁed by chemiluminescence using an imag-
ing AutoChemiTM UVP BioImagin System (LTF Labortechnik).
β-actin was quantiﬁed and used as a loading control (anti-β-actin,
Sigma, cat. no. A5316, diluted 1:1000).
STATISTICAL ANALYSIS
Data are expressed as the mean ± standard error of the mean
(SEM) for at least eight determinations per experimental group.
Statistical signiﬁcance for behavioral data was assessed by one-
way/repeated measures analysis of variance (ANOVA) and a post
hoc Newman–Keuls test. Statistical signiﬁcance of gene and pro-
tein quantiﬁcation was obtained by two-wayANOVA with the two
factors being chronic pretreatment (conditioning with vehicle or
cocaine for 5 days) and acute treatment (vehicle or cocaine for
1 day), followed by Bonferroni test as a priori non-orthogonal
contrast test. P < 0.05 was considered statistically signiﬁcant.
RESULTS
COCAINE-ASSOCIATED BEHAVIORS
Figure 1A shows a schematic representation of the schedule
used for analysis of cocaine-associated behaviors. Brieﬂy, it
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included the analysis of locomotion in the open ﬁeld during
repeated cocaine administration (5 days-cocaine conditioning),
a 5 days-resting period, 1 day for testing CL and 1 day for
testing CS (priming). Mice pretreated with vehicle for 5 days,
rested and then treated with vehicle (vehicle–vehicle group) were
used as the baseline for locomotion (Figure 1B). Mice pre-
treated with vehicle and then treated with one administration
of cocaine (10 mg/kg; vehicle–cocaine group) showed a signif-
icant increase in locomotor activity (∗∗∗P < 0.001) compared
with the vehicle–vehicle group. After 5 days of cocaine condi-
tioning (20 mg/kg) and 5 days of resting, animals were then
subjected to an administration of vehicle or cocaine (10 mg/kg).
Repeated cocaine-conditioned animals receiving vehicle (cocaine–
vehicle group) showed an increase in locomotion, reﬂecting the
acquisition of a CL response (∗∗∗P < 0.001) compared with
the vehicle–vehicle group (non-conditioned control group). This
effect was produced by association between the features of the
environment and the rewarding properties of cocaine after 5 days
of injections. Repeated cocaine-conditioned animals receiving
cocaine (cocaine–cocaine group) showed a signiﬁcant CS response
as a consequence of signiﬁcantly higher locomotor activity com-
pared with the conditioning vehicle groups (vehicle–vehicle,
∗∗∗P < 0.001 and vehicle–cocaine, ##P < 0.01). Moreover, CS-
associated locomotor activity (cocaine–cocaine group) was sig-
niﬁcantly higher ($$$P < 0.001) than CL (cocaine–vehicle group;
Figure 1B).
GENE EXPRESSION OF CATECHOLAMINE BIOSYNTHESIS
To address whether cocaine treatment was associated with alter-
ations in the state of the catecholaminergic system, we ana-
lyzed the gene expression of TH, the rate-limiting enzyme in
catecholamine biosynthesis, in the cerebellum of the vehicle–
vehicle (V–V), vehicle–cocaine (V–C), cocaine–vehicle (C–V), and
cocaine–cocaine (C-C) mice. Acute cocaine exposure (vehicle–
cocaine group) induced a decrease in TH gene expression
(∗P< 0.05) compared with the vehicle–vehicle group (Figure 1C).
Repeated cocaine-conditioned animals receiving vehicle (cocaine–
vehicle group) or cocaine (cocaine–cocaine group) did not
show any effect on TH expression derived from acute treat-
ment, chronic pre-treatment or the interaction between these
factors.
GENE AND PROTEIN EXPRESSION OF eCB SIGNALING COMPONENTS
To address the possible neuroadaptive changes in relevant com-
ponents of eCB signaling associated with the effects of acute
cocaine exposure and cocaine conditioning or sensitization, we
analyzed the gene and protein expression of CB1 receptors and
the enzymes of eCB synthesis (DAGLα/β and NAPE-PLD) and
degradation (FAAH and MAGL) in the cerebellum of vehicle–
vehicle (V–V), vehicle–cocaine (V–C), cocaine–vehicle (C–V), and
cocaine–cocaine (C–C) mice. To analyze whether the differential
expression of either eCB producing or degrading enzymes can
result in altered eCB tone in the cerebellum in the four experimen-
tal groups, we also calculated the ratios between NAPE-PLD and
FAAH expression and between DAGLα/β and MAGL expression.
These ratios can suggest possible changes in N-acylethanolamines
(NAEs) and 2-arachidonylglycerol (2-AG) levels, respectively.
FIGURE 1 | (A) Schematic representation of the different phases of cocaine
behavior such as acute cocaine administration (10 mg/kg), cocaine
conditioning (20 mg/kg), resting, conditioned locomotion (CL) and cocaine
sensitization (CS, 10 mg/kg). (B) Effect of acute cocaine administration
(chronic vehicle + acute cocaine), CL (chronic cocaine + acute vehicle) and
cocaine sensitization (chronic cocaine + acute cocaine) on distance traveled
for 30 min measured in the Open Field. Box-and-whisker diagram
represents the statistical distribution of the data (n = 8/group).
Newman–Keuls: ∗∗∗P < 0.001 vs. vehicle–vehicle group, ##P < 0.01 vs.
vehicle–cocaine group, $$$P < 0.001 vs. cocaine–vehicle group.
(C) Relative mRNA levels of the catecholamine synthesizing enzyme
tyrosine hydroxylase (TH) in the mouse cerebellum after chronic
pretreatment (vehicle and cocaine) and acute treatment (vehicle and
cocaine). Histograms represent the mean ± SEM (n = 8/group). Two-way
ANOVA: ns, no signiﬁcance. Bonferroni: ∗P < 0.05 vs. vehicle–vehicle
group.
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Western blot analysis showed that antibodies used against the
components of the eCB signaling system revealed bands with
expected molecular weights in the cerebellum, as was previously
described (Suarez et al., 2008). CB1 immunoblotting revealed a
prominent band at approximately 60 kD, NAPE-PLD at 46 kD,
FAAH at 63 kD, DAGLα at 120 kD, DAGLβ at 76 kD, and MAGL
at 35–37 kD.
eCB mRNA levels in the cerebellum
Two-way ANOVA analysis only showed a chronic pretreatment
effect in CB1 gene expression (F1,27 = 10.73, P = 0.0029;
Figure 2A). Signiﬁcant effects of acute treatment were also found
in the cerebellar gene expression of CB1 and DAGLα and the
DAGLα/MAGL ratio (CB1: F1,27 = 5.66, P = 0.024; DAGLα:
F1,27 = 4.44,P = 0.044; DAGLα/MAGL:F1,27 = 16.52,P = 0.0004;
Figures 2A,D,H). Interaction between factors was detected in
the gene expression of CB1 and the DAGLα/MAGL ratio (CB1:
F1,27 = 5.66, P = 0.024; DAGLα/MAGL: F1,27 = 4.57, P = 0.041;
Figures 2A,H), indicating that acute treatment with cocaine did
not have the same effect on the gene expression of CB1 and the
DAGLα/MAGL ratio after chronic pretreatment. Bonferroni anal-
ysis showed that acute cocaine (vehicle–cocaine group) induced a
decrease in CB1 gene expression (∗∗P< 0.01), DAGLα (∗P< 0.05)
and the DAGLα-β/MAGL ratio (∗∗∗P < 0.001 and ∗P < 0.05,
respectively), but not in gene expression of NAPE-PLD, FAAH,
DAGLβ and MAGL or the NAPE-PLD/FAAH ratio (Figure 2).
Repeated cocaine-conditioned animals receiving vehicle (cocaine–
vehicle group) or cocaine (cocaine–cocaine group) showed no
effect on gene expression in the eCB signaling components ana-
lyzed compared with the vehicle–vehicle group. However, the
FIGURE 2 | Relative mRNA levels of components of the eCB
signaling system [CB1 (A), NAPE-PLD (B), FAAH (C), DAGLα
(D), DAGLβ (E), MAGL (F), NAPE-PLD (G), DAGLα/MAGL (H), and
DAGLβ/MAGL (I)] in the mouse cerebellum after chronic
pretreatment (vehicle and cocaine) and acute treatment (vehicle
and cocaine). Histograms represent the mean ± SEM (n = 8/group).
Two-way ANOVA: ns, no signiﬁcance; ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001. Bonferroni: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs.
vehicle–vehicle group; #P < 0.05, ##P < 0.01, ###P < 0.001 vs.
vehicle–cocaine group.
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cerebella of the repeated cocaine-conditioned animals receiv-
ing vehicle presented increased CB1 and DAGLα mRNA levels
(##P < 0.01 and #P < 0.05, respectively), whereas repeated
cocaine-conditioned animals receiving cocaine only showed an
increase in CB1 mRNA levels (###P < 0.001) compared with the
vehicle–cocaine group (Figures 2A,D).
eCB protein levels in the cerebellum
Figure 3A illustrates representative immunoblots showing protein
expression of the eCB components analyzed in the cerebellum of
the four experimental groups (V–V, V–C, C–V, and C–C). Two-
way ANOVA analysis showed a chronic pretreatment effect only
in the NAPE-PLD/FAAH ratio (F1,12 = 10.31, P = 0.0075) and
DAGLβ/MAGL ratio (F1,12 = 6.02, P = 0.0304; Figures 3H,J), but
not in the remaining eCB components. A signiﬁcant effect of acute
treatment was not observed in the cerebellar protein expression
of the eCB components analyzed. Interaction between factors was
not detected, indicating that acute cocaine treatment had the same
effect on the protein expression of the eCB components as chronic
pretreatment. Bonferroni analysis showed that acute cocaine
(vehicle–cocaine group) induced a decrease in the gene expres-
sion of DAGLα, but not in the gene expression of the remaining
eCB components and ratios analyzed (Figure 3). The cocaine–
vehicle group showed an increase in the NAPE-PLD/FAAH ratio
(∗∗P < 0.01) and a decrease in the DAGLβ/MAGL (∗P < 0.05)
ratio comparedwith the vehicle–vehicle group (Figures 3H,J). The
cocaine–cocaine group showed lower protein expression of FAAH
andDAGLβ, a lowerDAGLβ/MAGL ratio and a higherNAPE-PLD
ratio compared with the vehicle–vehicle group (∗P < 0.05 in all
cases; Figures 3D,F,H,J).
GENE EXPRESSION OF GLUTAMATE SIGNALING COMPONENTS
To address whether the cocaine behavior-related changes observed
in eCB signaling components were associated with an alter-
ation in the glutamatergic state, we analyzed the gene expres-
sion of the glutamate synthesizing enzymes LGA and KGA,
mGluR3/5 metabotropic receptors, and NR1/2A/2B/2C-NMDA
and GluR1/2/3/4-AMPA ionotropic receptor subunits in the cere-
bellum of the vehicle–vehicle (V–V), vehicle–cocaine (V–C),
cocaine–vehicle (C–V), and cocaine–cocaine (C–C) mice.
Two-way ANOVA analysis showed a chronic pretreatment
effect in the gene expression of NR1, GluR1 and GluR4 (NR1:
F1,28 = 4.60, P = 0.04; GluR1: F1,28 = 5.49, P = 0.026; GluR4:
F1,28 = 4.53, P = 0.042; Figures 4E,I,L). Signiﬁcant effects of
the acute treatment were only observed in the cerebellar gene
expression of LGA (F1,28 = 4.30, P = 0.047; Figure 4A). Inter-
action between factors was also found in the NR1, NR2A, NR2C
and GluR1 mRNA levels (NR1: F1,28 = 9.17, P = 0.0052; NR2A:
F1,28 = 6.31, P = 0.018; NR2C: F1,28 = 8.46, P = 0.007; GluR1:
F1,28 = 5.20, P = 0.0304; Figures 4E,F,H,I), indicating that acute
FIGURE 3 | Representative immunoblots (A) and relative protein levels of
components of the eCB signaling system [CB1 (B), NAPE-PLD (C), FAAH
(D), DAGLα (E), DAGLβ (F), MAGL (G), NAPE-PLD (H), DAGLα/MAGL
(I), and DAGLβ/MAGL (J)] in the mouse cerebellum after chronic
pretreatment (vehicle and cocaine) and acute treatment (vehicle and
cocaine). Histograms represent the mean ± SEM (n = 8/group). Two-way
ANOVA: ns, no signiﬁcance; ∗P < 0.05, ∗∗P < 0.01. Bonferroni: ∗P < 0.05,
∗∗P < 0.01 vs. vehicle–vehicle group.
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FIGURE 4 | Relative mRNA levels of components of the glutamate
signaling system [LGA (A), KGA (B), mGluR3/5 (C,D), NR1/2A/2B/2C
(E–H), and GluR1/2/3/4 (I–L) and EAAC1 (M)] in the mouse
cerebellum after chronic pretreatment (vehicle and cocaine) and
acute treatment (vehicle and cocaine). Histograms represent the
mean ± SEM (n = 8/group). Two-way ANOVA: ns, no signiﬁcance;
∗P < 0.05, ∗∗P < 0.01. Bonferroni: ∗P < 0.05, ∗∗P < 0.01 vs.
vehicle–vehicle group.
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treatment of cocaine differentially affects gene expression of NR1,
NR2A, NR2C and GluR1 in a chronic pretreatment-dependent
manner. Bonferroni analysis indicated that acute cocaine exposure
(vehicle–cocaine group) induced a decrease in the gene expres-
sion of most glutamate signaling components analyzed, such as
KGA (∗P < 0.05), mGluR3 (∗P < 0.05), NR1 (∗∗P < 0.01),
NR2A (∗∗P < 0.01), NR2B (∗P < 0.05), NR2C (∗P < 0.05),
GluR1(∗P < 0.05), GluR2 (∗P < 0.05), GluR3 (∗P < 0.05),
and GluR4 (∗P < 0.05), compared with the vehicle–vehicle
group (Figure 4). Repeated cocaine-conditioned animals receiv-
ing vehicle (cocaine–vehicle group) did not show any signiﬁcant
change in the gene expression of the glutamate components ana-
lyzed. Repeated cocaine-conditioned animals receiving cocaine
(cocaine–cocaine group) only showed a signiﬁcant increase inLGA
mRNA levels comparedwith the vehicle–vehicle group (∗P< 0.05;
Figure 4A).
DISCUSSION
The present study conﬁrms that the eCB signaling system is amod-
ulatory system that differentially modiﬁes the expression of its
components as a result of acute versus repeated cocaine exposure
in the cerebellum. Overall, the data suggest that, in this central
nervous system structure, acute cocaine exposure reduced the
expression of the 2-AG-synthesizing enzyme DAGLα. As a conse-
quence, the ratio of DAGLα/MAGL dropped, suggesting reduced
production of the endocannabinoid 2-AG, which is responsible
for inhibiting the excitatory glutamatergic inputs of granule cells
because DAGLα is expressed in Purkinje dendrites (Suarez et al.,
2008). No changes were observed in the machinery that produces
anandamide (AEA), the secondmajor endocannabinoid. Repeated
administration of cocaine resulted in a differential response in
the 2-AG and AEA turnover machinery. Data associated with CS
after chronic cocaine administration indicated decreased protein
expression of FAAH and DAGLβ [production in Purkinje den-
drites and cell bodies described by Suarez et al. (2008)], suggesting
opposite availabilities for N-acylethanolamides (NAEs) and 2-AG,
respectively. The lack of eCB-mediated inhibition might be par-
tially responsible for the well-described hyperglutamatergic state
associated with prolonged cocaine action (Cornish and Kalivas,
2000). Thus, after chronic cocaine exposure, we observed an acti-
vated glutamatergic state in the cerebellum as a consequence of
increased expression of the glutamate synthetizing enzyme LGA
and normalized expression of all metabotropic and ionotropic
glutamate receptors. In contrast, after acute cocaine exposure,
we observed a down-regulation of the expression of the gluta-
mate synthetizing enzyme KGA, which can reﬂect a hypoactivated
glutamatergic state in the cerebellum. This hypothetic hypoglu-
tamatergic state was associated with decreased expression of key
signaling receptors such as the metabotropic mGluR3 receptor
and all subunits of both ionotropic (NMDA and AMPA) glu-
tamate receptors. Because cerebellar circuits are involved in the
control of motor planning, motor learning, execution and coor-
dination, an intact endogenous cannabinoid system is required
to regulate sensorimotor integration. Our hypothesis is as fol-
lows: (1) An excessive deﬁcit of 2-AG production after acute
cocaine exposure may facilitate glutamate-mediated activation
of Purkinje inhibitory GABAergic transmission, leading to a
compensatory hypoglutamatergic (biosynthesis of the enzyme
KGA and glutamate receptors) state in the cerebellum. This dys-
regulation of both the eCB and glutamate signaling systems can
result in disrupted control of action and coordination, especially
in sensorimotor integration. (2) The decreased expression of the
eCB-degradation FAAH and eCB-producer DAGLβ, which sug-
gest opposite tones for NAEs and 2-AG, respectively, could be
explained by a neuroadaptation of the eCB signaling system to
chronic cocaine exposure that ﬁnally leads to a hyperactivated
glutamatergic state (biosynthesis enzyme LGA) in the cerebellum
(see Table 2 for summary).
Analysis of the expression of the synthesis pathways for eCB
revealed that DAGLα was reduced in the cerebellum of acute
cocaine-exposed animals. The trend of the relative synthetiz-
ing/degrading enzymes suggested a decrease in 2-AG and no
change in AEA. Because acute ﬁrst exposure to cocaine increased
Table 2 | Summary of the main effects observed on the
endocannabinoid and glutamate systems after acute cocaine,
conditioning locomotion, and cocaine sensitization1.





CB1 ↓∗∗ – ↑## – ↑## –
NAPE-PLD – – – – – –
FAAH – – – – – ↓∗
DAGLα ↓∗ ↓∗ ↑# – – –
DAGLβ – – – – – ↓∗
MAGL – – – – – –
NAPE-PLD/FAAH – – – ↑∗∗ – ↑∗
DAGLα/MAGL ↓∗∗∗ – – – – –
DAGLβ/MAGL ↓∗ – – ↓∗ – ↓∗
Glutamatergic system
mRNA levels
LGA – – ↑∗
KGA ↓∗ – –
mGluR3 ↓∗ – –
mGluR5 – – –
NR1 ↓∗∗ – –
NR2A ↓∗∗ – –
NR2B ↓∗ – –
NR2C ↓∗ – –
GluR1 ↓∗ – –
GluR2 ↓∗ – –
GluR3 ↓∗ – –
GluR4 ↓ ∗ – –
EAAC1 – – –
TH ↓∗ – –
1∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. vehicle–vehicle group; #P < 0.05,
##P < 0.01 vs. vehicle–cocaine group.
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eCB formation, most likely via the activation of DA D2 recep-
tors in the striatum (Giuffrida et al., 1999; Centonze et al., 2004),
we hypothesized that, in the cerebellum, acute administration of
cocaine might lead to a hyposensitization of the noradrenergic-
driven (most likely beta-receptor mediated) eCB inhibitory signal
and, as a consequence, a hyposensitization of the eCB-driven glu-
tamatergic excitatory signal. There is strong evidence that eCBs
modulate noradrenergic signaling (Kirilly et al., 2013). This sig-
naling effect can be addressed by adapting the machinery needed
for 2-AG (DAGLα) and glutamate (KGA) production.
Regarding the adaptations observed in the eCB signaling sys-
tem, acute cocaine caused a decrease inCB1mRNA levels but, after
chronic cocaine exposure, CB1 gene expression returned to ini-
tial levels (compared with the vehicle–vehicle group). Compared
with the vehicle–cocaine group, prolonged exposure produced
an increase in the CB1 gene (but not protein) expression in the
cerebellum, which can be mainly associated with an increase in
the NAPE-PLD/FAAH ratio and a decrease in the DAGLβ/MAGL
ratio (observed at the protein level). This combination is sugges-
tive of an increased availability of NAEs and a reduced availability
of 2-AG, respectively, which may be induced by CS after chronic
cocaine administration. Although a previous report indicated that
enhanced bioavailability of AEA, derived from inhibition of either
AEA uptake or AEA degradation, attenuated behavioral responses
to cocaine (Chaperon et al., 1998; Fattore et al., 1999; Adamczyk
et al., 2009), our results suggest that in the absence of external
pharmacological manipulation of eCB production, endocannabi-
noid neuroadaptations are insufﬁcient to compensate for the
overactivity derived from chronic cocaine treatments. Thus, the
up-regulation of CB1 gene expression (most likely associated with
the local circuitry of the cerebellar cortex) and the increased avail-
ability of AEA cannot counteract glutamatergic overactivity. The
decrease in 2-AG, which is the main retrograde signal, is not suf-
ﬁciently compensated by enhanced AEA. Supporting this ﬁnding,
a recent report by Orio and co-workers (Orio et al., 2009) showed
that AEA and 2-AG release, as measured by microdialysis, was
reduced in rats self-administering cocaine. This ﬁnding was asso-
ciated with enhanced expression of CB1 receptors. In a previous
study by our group (Rivera et al., 2013), we demonstrated a similar
ﬁnding in the Hc of Lewis rats self-administering cocaine. More-
over, we cannot ignore the possibility that the observed changes
in NAPE-PLD/FAAH may involve non-CB1-acting endocannabi-
noids, such as oleoylethanolamide (OEA). This interpretation
arises because beta-adrenergic activation stimulates synthesis of
OEA in response to cold exposure in adipocytes and to sati-
ety in the small intestine (LoVerme et al., 2006; Fu et al., 2011).
Moreover, OEA has been recently proposed to control cocaine-
associated behaviors (Bilbao et al., 2013). Concerning the CB2
receptor, although we have not measured its expression in the
present study, we cannot rule out a role for this receptor in the
neuroadaptive responses to cocaine, as recently suggested (Xi et al.,
2011; Aracil-Fernandez et al., 2012).
Glutamate seems to be a primary mediator of cocaine-induced
behaviors associated with drug-seeking (Cornish and Kalivas,
2000). For instance, stimulation of glutamate receptors in the
NAc augments the reinforcing effect of cocaine, and increased
glutamatergic neurotransmission may be involved in facilitating
relapse to cocaine-seeking behavior (Cornish et al., 1999). Acti-
vation of group I (mGluR1/5) metabotropic receptors resulted in
an increase in NAc extracellular glutamate levels (Swanson et al.,
2001). Moreover, stimulation of mGluR5 in the PFCx is sufﬁcient
to induce CS (Timmer and Steketee, 2012), whereas the adminis-
tration of mGluR5 antagonists attenuated cocaine priming- and
cue-induced reinstatement of cocaine seeking (Platt et al., 2008;
Kumaresan et al., 2009). Our present data agree with these ﬁnd-
ings, suggesting the induction of glutamate synthesis (increased
LGA gene expression) in CS after chronic cocaine exposure. How-
ever, the increase in the glutamate synthesizing enzyme LGA is
not associated with an enhancement of the expression of any
metabotropic or ionotropic glutamate receptor analyzed as a com-
pensatory mechanism to counteract the putative hyperactivation
of these receptors.
In summary, acute and chronic cocaine exposure differentially
modulates the expression of the eCB and glutamate signaling
machinery in the cerebellar cortex. After acute cocaine expo-
sure, the changes are compatible with a situation in which
the reduced inhibitory actions of 2-AG on glutamatergic termi-
nals cause decreased synthesis of catecholamine and glutamate.
After repeated cocaine exposure, increased synthesis of glutamate
results fromdysregulation of eCB availability (increasedNAEs and
decreased 2-AG) in the cerebellum. This situation can contribute
to the induction of behavioral sensitization, a process thought to
be relevant for psychostimulant addiction.
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